Pancreatic cancer: Intra-tumour bacteria promote gemcitabine resistance in pancreatic adenocarcinoma

Nature Reviews Gastroenterology and Hepatology

Volumn 14, Issue 11, 2017, Pages 632-

  Thomas, Hugh ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CYTIDINE DEAMINASE; GEMCITABINE; DEOXYCYTIDINE;

BACTERIUM; BACTERIUM IDENTIFICATION; CANCER CELL; CELL GROWTH; DRUG RESISTANCE; ESCHERICHIA COLI; GAMMAPROTEOBACTERIA; HUMAN; MYCOPLASMA; NONHUMAN; NOTE; PANCREAS ADENOCARCINOMA; PRIORITY JOURNAL; SKIN FIBROBLAST; STROMA CELL; TUMOR IMMUNITY; TUMOR MICROENVIRONMENT; TUMOR VASCULARIZATION; ADENOCARCINOMA; ANALOGS AND DERIVATIVES; PANCREAS TUMOR;

ADENOCARCINOMA; BACTERIA; DEOXYCYTIDINE; HUMANS; PANCREATIC NEOPLASMS;

EID: 85032452888     PISSN: 17595045     EISSN: 17595053     Source Type: Journal    
DOI: 10.1038/nrgastro.2017.142     Document Type: Note

References (1)

1. Geller, L. T. et al. Potential role of intratumor bacteria in mediating tumor resistance to the chemotherapeutic drug gemcitabine. Science 357, 1156-1160 (2017)